The Magtrace® lymphatic tracer is the world’s first, non-radioactive dual tracer for lymphatic mapping in patients with breast cancer. Made from just four ingredients, iron oxide, sugar, salt and water, Magtrace® provides a simple solution for breast cancer staging. Designed specifically for sentinel lymph node biopsies, this magnetic liquid provides a more accurate and efficient way to locate, stage and remove breast cancer tissue. Its long injection window is also opening up opportunities for more advanced techniques helping to reduce and de-escalate surgery. Now used in over 1,350 centers in more than 45 countries, Magtrace® has helped over 186,000 breast cancer patients access the best standard of breast cancer care across the world.